A single trading halt lit a fire under one small-cap, while a string of fundraisings reminded investors how often growth still needs fresh cash. Elsewhere, “AI-first” is splitting into two camps: products that ship now, and stories that still need proof.
- BluGlass jumped on a pending customer order and stayed strong after the halt.
- Spenda led the falls after a heavily discounted placement priced at $0.002 a share.
- Dicker Data slid despite locking in a fully franked dividend and DRP price for March.
- Several micro-caps leaned on funding structures (convertible notes, R&D-backed facilities, rights issues) to keep plans moving.
- Edge AI and real-time “digital human” tech pushed forward, but share moves were mixed.
BluGlass (ASX:BLG) dominated the tape with a 65.00% weekly surge after the company said it is finalising a significant customer order and requested a trading halt while it prepares a formal update due 9 March. Spenda (ASX:SPX) slid 16.67% after raising $1.4 million at $0.002 a share, a price that can reset expectations for what the stock is worth right now. Dicker Data (ASX:DDR) fell 14.33% even as it confirmed an 11.5 cent fully franked dividend and set the DRP reinvestment price.
Trading halts and gap moves: what investors paid for
Buying in BluGlass didn’t fade after the halt. Put simply, traders kept paying up because the next announcement has a clear date (9 March) and the company linked the move to a real-world trigger: a customer order. Identitii (ASX:ID8) went the other way, down 12.50% for the week after its rights issue raised $379,336 and left a $2.5 million shortfall. Its securities were reinstated after the offer closed and a Takeovers Panel application was resolved. The price action suggested nervousness: the stock re-opened at a lower level and then didn’t recover in the session. Investors often worry when there is still stock to be placed later, because more shares can be sold into the market.Fundraising week: keeping the lights on versus buying growth
Several names leaned on fresh funding to keep product work and sales pushes moving. Spenda’s placement brought in new and existing sophisticated investors, with directors and executives pledging $570,000 subject to shareholder approval. The immediate risk for existing holders is simple: more shares on issue can spread future profits across a bigger base. Complii FinTech Solutions (ASX:CF1) secured $2 million via unsecured convertible notes paying 12% interest. That interest bill matters because it is cash that must be paid or rolled over. Conversion can also mean more shares later if the notes turn into equity. ClearVue Technologies (ASX:CPV) took a different route, using a $3 million structured facility tied to its FY26 R&D tax credit. That is designed to avoid issuing new shares now, but it still needs the tax refund to land as expected.AI gets practical: always-on voice, streaming avatars, and “ultra edge” chips
Nanoveu (ASX:NVU) talked up EMASS’s reference design for always-on voice in hearables, using jaw movement as a trigger to cut power use. In plain terms, it aims to keep voice listening “on” without killing the battery or sending audio to the cloud. Unith (ASX:UNT) released its Streaming Avatars tech to customers, claiming roughly 80% lower response delay. That matters because people stop using voice and avatar tools when replies feel laggy. dorsaVi (ASX:DVL) formed a Technical Advisory Board for its “Intelligence at the Ultra Edge” plan. The goal is to put sensing, memory and computing together on tiny chips so devices can react fast without heavy power draw. This week’s share move was modest, but the next proof point is whether the company can turn that lab-level ambition into a product partners will pay for.Recurring revenue and leadership changes: results help, but the market stayed picky
Life360 (ASX:360) posted a standout 2025: revenue hit $489.5 million, monthly active users rose 20% to 95.8 million, and it delivered its first full-year net profit of $150.8 million. Even so, the stock ended the week down 10.99%. That disconnect can happen when investors decide the good news was already priced in, or when they want to see the 2026 guidance turn into actual quarterly results. Stakk (ASX:SKK) moved higher 5.00% after adding nine institutional clients and $1.67 million in incremental ARR in February, with management pointing to strong gross margins and zero churn over 36 months. Straker (ASX:STG) fell 11.11% after naming two Co-CEOs effective 20 March 2026 and moving founder Grant Straker to a board role. Leadership changes can spook investors because they raise a basic question: who is really in charge when results miss?Bottom Line?
The next near-term catalyst is BluGlass’s promised update on 9 March. In the weeks after that, investors are likely to focus on whether recent fundraisings translate into visible sales progress, and whether announced leadership and product upgrades start showing up in simpler metrics like paying customers and recurring revenue.
Questions in the middle?
- BluGlass: when the customer order is announced, will it include delivery dates and dollar value, or just a headline agreement?
- Identitii: how quickly can the $2.5 million shortfall be placed, and at what price compared with recent trading?
- Spenda and Complii: will the new cash reduce costs and lift sales, or will more funding be needed before results improve?